Mesoblast completes Phase 3 low back pain trial treatment as pivotal readout approaches
Mesoblast has completed treatment of 350 patients in its pivotal Phase 3 trial for chronic low back pain, with results expected in mid-2027.
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| TOV | Ann: CVV Panel Receives Review Application | 24/04/18 | 0 | 18 | |||
|
|||||||
| TOV | Ann: CVV Panel Declines to Make Declaration | 20/04/18 | 0 | 32 | |||
|
|||||||
| TOV | Ann: Strategic Minerals Corporation NL Further Variations Orders | 11/04/18 | 0 | 30 | |||
|
|||||||
| TOV | Ann: Auris Minerals Limited Panel Declines to Conduct Proceedings | 06/04/18 | 0 | 47 | |||
|
|||||||
| TOV | Ann: Strategic Minerals Corporation NL Variation of Orders | 05/04/18 | 0 | 54 | |||
|
|||||||
| TOV | Ann: Auris Minerals Limited Panel Receives Application | 03/04/18 | 0 | 54 | |||
|
|||||||
| TOV | Ann: Finders Resources Limited 02 Panel Receives Application | 29/03/18 | 0 | 50 | |||
|
|||||||
| TOV | Ann: CVV Caravel Minerals Limited Panel Receives Application | 26/03/18 | 0 | 52 | |||
|
|||||||
See All Discussions
ASX News